- Home
- ELF vs ROIV Comparison
ELF vs ROIV Comparison
Compare ELF & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELF
- ROIV
- Stock Information
- Founded
- ELF 2004
- ROIV 2014
- Country
- ELF United States
- ROIV United Kingdom
- Employees
- ELF N/A
- ROIV N/A
- Industry
- ELF Package Goods/Cosmetics
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- ELF Consumer Discretionary
- ROIV Health Care
- Exchange
- ELF Nasdaq
- ROIV Nasdaq
- Market Cap
- ELF 7.4B
- ROIV 8.4B
- IPO Year
- ELF 2016
- ROIV N/A
- Fundamental
- Price
- ELF $131.51
- ROIV $10.94
- Analyst Decision
- ELF Strong Buy
- ROIV Strong Buy
- Analyst Count
- ELF 16
- ROIV 8
- Target Price
- ELF $167.94
- ROIV $17.93
- AVG Volume (30 Days)
- ELF 1.2M
- ROIV 5.3M
- Earning Date
- ELF 02-04-2025
- ROIV 02-11-2025
- Dividend Yield
- ELF N/A
- ROIV N/A
- EPS Growth
- ELF N/A
- ROIV N/A
- EPS
- ELF 1.86
- ROIV 5.89
- Revenue
- ELF $1,217,638,000.00
- ROIV $129,128,999.00
- Revenue This Year
- ELF $31.75
- ROIV $15.98
- Revenue Next Year
- ELF $16.60
- ROIV N/A
- P/E Ratio
- ELF $70.80
- ROIV $1.86
- Revenue Growth
- ELF 59.01
- ROIV 145.68
- 52 Week Low
- ELF $98.50
- ROIV $9.69
- 52 Week High
- ELF $221.83
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- ELF 54.28
- ROIV 38.75
- Support Level
- ELF $123.89
- ROIV $10.42
- Resistance Level
- ELF $133.33
- ROIV $11.82
- Average True Range (ATR)
- ELF 5.07
- ROIV 0.35
- MACD
- ELF -0.03
- ROIV -0.11
- Stochastic Oscillator
- ELF 65.75
- ROIV 29.21
About ELF e.l.f. Beauty Inc.
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skin care products. The Company's mission is to make the best of beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women which include eyeliner, mascara, false eyelashes, lipstick, the foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels. The products that the company sells are marketed under the e.l.f. Cosmetics, W3LL PEOPLE and Keys Soulcare brands. It carries out sales within the US and internationally, out of which maximum revenue is generated from the US.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.